News

Quantum machine learning, an approach that combines machine learning and quantum physics, is being investigated as a means to discover possible treatments for COVID-19.

A team of researchers has studied how brain alterations at a functional level in mice with Down syndrome respond to chronic treatment with a component of green tea, that we know, from other studies, improves executive functions in adults.

Researchers have used computer-aided drug design to examine the effectiveness of four drugs; remdesivir, 5-fluorouracil, ribavirin and favipiravir in treating COVID-19. They found that all four drugs were effective in inhibiting, or blocking, the coronavirus’ RNA proteins from making genomic copies of the virus.

Scientists have screened 48 FDA-approved drugs against SARS-CoV-2, and found that 2, niclosamide and ciclesonide, which are already FDA-approved for other indications, appear promising.

Researchers at Utrecht University, Erasmus Medical Center and Harbour BioMed (HBM) today reported that they have identified a fully human monoclonal antibody that prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells.

Skoltech researchers have identified a set of proteins that are important in the process of apoptosis, or programmed cell death. These newly identified proteins can become targets in the development of drugs against cancer or other diseases.

Understanding the principles of cancer evolution is important in designing a therapeutic strategy. A research group at The Institute of Medical Science, The University of Tokyo (IMSUT) announced a new simulation model that describes various modes of cancer evolution in a unified manner.

A study published in the journal Cell outlines a novel avenue for potentially treating COVID-19 – antibodies from a llama. The research is a collaborative effort from The University of Texas at Austin (UT Austin), the National Institutes of Health and Ghent University in Belgium

Involuntary movements caused by dopamine replacement therapy can be alleviated through suppression of RasGRP1, a new study has suggested.

Researchers have shown that it is possible to control how crystals grow – including inducing them to form hollow crystal spheres.